arrow
B

Bérangère S. Joly

assistance publique hopitaux paris (aphp)
H指数:22
被引数:2,267

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-time, multidisciplinary approach of women with pregnancy-associated thrombotic microangiopathy

妊娠相关性血栓性微血管病女性的实时、多学科方法

2026-06-180
OAAI
Health-Related Quality of Life and Mental Health in Autoimmune Thrombotic Thrombocytopenic Purpura Patients in the Caplacizumab Era

与自身免疫性血栓性血小板减少性紫癜患者相关的生命质量及心理健康——卡普拉昔珠单抗时代的现状

2025-12-090
OAAI
Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

优化ADAMTS13预防治疗以减少先天性血栓性血小板减少性紫癜的复发和器官衰竭

2025-09-010
OAAI
Correction: Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025

更正: 血栓性血小板减少性紫癜: 早期诊断和有效治疗2025年

2025-07-220
PREAI
Anti-ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune-Mediated TTP

抗ADAMTS13抗体轨迹与免疫介导性TTP中ADAMTS13恢复相关

2025-07-150
OAAI
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025

血栓性血小板减少性紫癜:2025年的早期诊断与有效治疗

2025-07-030
PRE
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Obinutuzumab治疗免疫介导的血栓性血小板减少性紫癜的疗效和安全性

2024-12-120
OAAI
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal Crisis

血管生物标志物可溶性fms样酪氨酸激酶和胎盘生长因子在硬皮病肾危象中诊断性能的初步研究

2024-12-010
OAAI
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura

开放ADAMTS-13构象指数预测免疫介导的血栓性血小板减少性紫癜的早期复发

2024-02-014
PRE